TherageniX delivers genes that direct the body to make necessary proteins or substances that aid in tissue regeneration.
TherageniX has raised $1.3M in total funding. The most recent round was Grant. The last funding was announced in August 2023.
TherageniX's investors include Innovate UK.
TherageniX is headquartered in London, United Kingdom.
TherageniX delivers genes that direct the body to make necessary proteins or substances that aid in tissue regeneration.
TherageniX is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TherageniX — Funding & Investors." VCBacked, August 31, 2023, https://www.vcbacked.co/company/theragenix. Accessed September 30, 2026.
VCBacked. (2023). TherageniX — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/theragenix
{{cite web |title=TherageniX — Funding & Investors |url=https://www.vcbacked.co/company/theragenix |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated